Overview

πCIT (Precision Chemo-/Immuno-Therapy) uses patient- & tumor-standard of care data collected at diagnosis to dynamically predict for the entire treatment landscape (including new FDA-approved drugs) and prior to treatment initiation: (1) leukemia response to therapy, (2) patient recovery from treatment and, (3) optimized therapy regimens for improved outcomes.